Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Apr;68(4):918-26.
doi: 10.1086/319509. Epub 2001 Feb 27.

Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci

S H Laval  1 , A Timms, S Edwards, L Bradbury, S Brophy, A Milicic, L Rubin, K A Siminovitch, D E Weeks, A Calin, B P Wordsworth, M A Brown
Affiliations

Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci

S H Laval et al. Am J Hum Genet. 2001 Apr.

Abstract

Ankylosing spondylitis (AS) is a common inflammatory arthritis predominantly affecting the axial skeleton. Susceptibility to the disease is thought to be oligogenic. To identify the genes involved, we have performed a genomewide scan in 185 families containing 255 affected sibling pairs. Two-point and multipoint nonparametric linkage analysis was performed. Regions were identified showing "suggestive" or stronger linkage with the disease on chromosomes 1p, 2q, 6p, 9q, 10q, 16q, and 19q. The MHC locus was identified as encoding the greatest component of susceptibility, with an overall LOD score of 15.6. The strongest non-MHC linkage lies on chromosome 16q (overall LOD score 4.7). These results strongly support the presence of non-MHC genetic-susceptibility factors in AS and point to their likely locations.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Multipoint results for screens 1 and 2 and the combined data set using the program GENEHUNTER PLUS. Screen 1 results are given with a dotted line, screen 2 with a dashed and dotted line, and the combined results with an unbroken line.
See this image and copyright information in PMC

References

Electronic-Database Information

    1. GeneMap’99, http://www.ncbi.nlm.nih.gov/genemap99/ (for marker positions)
    1. Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/ (for AS [MIM 106300]) - PubMed
    1. Whitehead Institute for Biomedical Research, http://www.genome.wi.mit.edu/ (for marker positions)

References

    1. Beyeler C, Armstrong M, Bird HA, Idle JR, Daly AK (1996) Relationship between genotype for the cytochrome P450 CYP2D6 and susceptibility to ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 55:66–68 - PMC - PubMed
    1. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD (1973) Ankylosing spondylitis and HL-A 27. Lancet 1:904–907 - PubMed
    1. Brown MA, Edwards S, Hoyle E, Campbell S, Laval S, Daly AK, Pile KD, Calin A, Ebringer A, Weeks DE, Wordsworth BP (2000a) Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis. Hum Mol Genet 9:1563–1566 - PubMed
    1. Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL, Taylor A, Calin A, Wordsworth P (1997) Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 40:1823–1828 - PubMed
    1. Brown MA, Laval SH, Brophy S, Calin A (2000b) Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis 59:883–886 - PMC - PubMed

Publication types